ImmuCell Q2 Net Income Soars 266% on $2M Settlement and Strong Sales
ICCC has more than doubled off its 52-week low of $4.52.
Summary
ImmuCell reported Q2 net income of $1.83 million ($0.20 EPS), up 266% year-over-year, boosted by a $2 million legal settlement and 11.5% sales growth. The 10-Q also revealed a USDA approval to extend colostrum expiration limits and plans for an $8 million manufacturing expansion.
Key Events · Earnings and Guidance · ICCC
-
Q2 Net Income Up 266%
Net income reached $1.83 million ($0.20 per diluted share) versus $0.50 million ($0.06) in Q2 2025, driven by an 11.5% increase in product sales to $7.19 million and a $2.0 million settlement gain.
-
$2M Settlement Boosts Results
The company recorded a $2.0 million settlement from Norbrook Laboratories as other operating income, resolving claims for operating costs related to the Re-Tain product development.
-
USDA Approval to Release Reserve
On July 31, 2026, the USDA approved an extension of expiration limits for colostrum, allowing ImmuCell to release a $233,665 inventory reserve to cost of goods sold in Q3 2026.
-
Manufacturing Expansion Underway
The Board authorized a two-phase expansion: Phase One ($3.5 million, ~12 months) adds freeze-drying capacity; Phase Two ($4.5 million, ~6 months) expands colostrum processing capacity.
Analysis · ICCC · Life Sciences
A one-time $2.0 million settlement from a former contract manufacturer and an 11.5% revenue increase drove ImmuCell's second quarter net income to $1.83 million, up from $0.50 million a year earlier. The company also disclosed a USDA approval that will release a $233,665 inventory reserve next quarter, and detailed a two-phase manufacturing expansion costing up to $8 million to meet growing demand for its First Defense product line.
At the time of this filing, ICCC was trading at $10.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $98.6M. The 52-week trading range was $4.52 to $12.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.